ファーマコビジランスおよび医薬品安全性ソフトウェアの世界市場:機能別、導入タイプ別(オンプレミス、オンデマンド・クラウドベース)、エンドユーザー別、地域別予測...市場調査レポートについてご紹介

【英文タイトル】Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast 2018- 2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS
Chapter 1. Global Pharmacovigilance and Drug Safety Software Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
Chapter 4. Global Pharmacovigilance and Drug Safety Software Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Pharmacovigilance and Drug Safety Software Market, By Functionality
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
5.3.1. Adverse Event Reporting Software
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Drug Safety Audits Software
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Issue Tracking Software
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Fully Integrated Software
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Pharmacovigilance and Drug Safety Software Market, By Delivery Mode
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
6.3.1. On Premise
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. On Demand / Cloud based
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Pharmacovigilance and Drug Safety Software Market, By End User
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
7.3.1. Pharma and Biotech Companies
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Contract Research Organizations (CROS)
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Business Process Outsourcing (BPO) Firms
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Pharmacovigilance and Drug Safety Software Market, by Regional Analysis
8.1. Global Pharmacovigilance and Drug Safety Software Market, Regional Market Snapshot (2015-2025)
8.2. North America Global Pharmacovigilance and Drug Safety Software Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.3. Europe Global Pharmacovigilance and Drug Safety Software Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.4. Asia Global Pharmacovigilance and Drug Safety Software Market Snapshot
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.5. Latin America Global Pharmacovigilance and Drug Safety Software Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.5.3. Rest of The World
8.5.4. South America
8.5.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

8.5.5. Middle East and Africa
8.5.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.5.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.5.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.5.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

Chapter 9. Company Profiles
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AB-Cube
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. ArisGlobal
9.3.3. Extedo GMBH.
9.3.4. Ennov.
9.3.5. Oracle Corporation
9.3.6. Online Business Applications, Inc
9.3.7. Sarjen Systems Pvt. Ltd
9.3.8. Sparta Systems, Inc
9.3.9. United Biosource Corporation
9.3.10. Umbra Global


【レポート販売概要】

■ タイトル:ファーマコビジランスおよび医薬品安全性ソフトウェアの世界市場:機能別、導入タイプ別(オンプレミス、オンデマンド・クラウドベース)、エンドユーザー別、地域別予測
■ 英文:Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast 2018- 2025
■ 発行日:2018年7月22日
■ 調査会社:Bizwit Research & Consulting
■ 商品コード:BZW808045
■ 調査対象地域:グローバル、日本、アメリカ、カナダ、英国、ドイツ、フランス、中国、インド、ブラジル、メキシコ
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。